CD4 and neoplasm: An immune-enriched tumor phenotype is characterized by the presence of various TILs, including CD4- and CD8-expressing effector T cells, as well as inhibitory Tregs, myeloid-derived suppressor cells, suppressor B cells, and CAFs.